CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,517,887
- in 19 filings, $4.9M under 10b5-1 plans
Net −$6,517,887. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −7,555 | $36.01 | $272K | 4,929 |
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,816 | $36.01 | $101K | 2,024 |
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,393 | $36.01 | $86K | 1,721 |
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,025 | $36.81 | $38K | 3,904 |
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −382 | $36.81 | $14K | 1,642 |
| 2026-11-02 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −325 | $36.81 | $12K | 1,396 |
| 2026-10-28 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −1,237 | $35.58 | $44K | 44,194 |
| 2026-10-28 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −5,341 | $36.62 | $196K | 38,853 |
| 2026-10-26 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −3,288 | $33.08 | $109K | 45,431 |
| 2026-10-19 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −8,580 | $31.91 | $274K | 12,484 |
| 2026-10-19 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,198 | $31.91 | $102K | 4,840 |
| 2026-10-19 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,718 | $31.91 | $87K | 4,114 |
| 2026-10-12 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −3,288 | $33.64 | $111K | 48,719 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +8,165 | $2.39 | $20K | 29,644 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −8,580 | $35.57 | $305K | 21,064 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,198 | $35.57 | $114K | 8,038 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,718 | $35.57 | $97K | 6,832 |
| 2026-10-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −8,165 | 0 | ||
| 2026-10-01 | Oelschlager Kristen M Chief Operating Officer | Option exercise 10b5-1 | +4,153 | $3.38 | $14K | 17,509 |
| 2026-10-01 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −2,807 | $35.75 | $100K | 14,702 |
Page 1 of 45 · 895 trades